On July 31, 2025, the Trump administration released “Winning the Race: America’s AI Action Plan.” CSET has broken down the Action Plan, focusing on specific government deliverables. Our Provision and Timeline tracker breaks down which agencies are responsible for implementing recommendations and the types of actions they should take.

CSET's Jacob Feldgoise and Hanna Dohmen outline China's market share gains in semiconductor manufacturing equipment, based on data from CSET ETO's updated Supply Chain Explorer.

Opposing narratives around AI for biotechnology raise the question: how are biotech researchers actually using AI in published research? CSET’s Steph Batalis, Catherine Aiken, and James Dunham explored this question by leveraging CSET’s merged academic corpus, enriched publication metadata, and research clusters.

Artificial intelligence is becoming more integrated into the sciences. One of the scientific fields experiencing this is computational biology, which uses computer modeling to understand biological mechanisms and systems. This blog post provides an understanding of important research trends in these subject areas, and how advancements in AI can improve the speed and efficiency of computational biology to improve human health and well-being.

Since 2022, U.S. export controls have restricted the highest-performing AI chips from being exported to China. The Biden administration likely did not intend to control CPUs (i.e., general-purpose processors) with these restrictions. However, CPUs are increasingly subject to export controls because chip designers are incorporating specialized elements for AI computation into CPUs. In this blog post, we discuss the implications of controlling AI-capable CPUs and make recommendations for the Bureau of Industry and Security (BIS) at the U.S. Department of Commerce.

Now that the first set of milestones has passed for the Biden administration’s October 2023 executive order on artificial intelligence, where do things stand for biotech? This blog post gives an overview of the most recent action items, with a recap of expert commentary from CSET’s June 2024 Webinar on the AIxBio Policy Landscape.

Over the past year, artificial intelligence has quickly become a focal point in K-12 education. This blog post describes new and existing K-12 AI education efforts so that U.S. policymakers and other decision-makers may better understand what’s happening in practice.

The Carnegie Classification of Institutions of Higher Education is making changes to drastically simplify the criteria that determine its highly coveted R1 top-tier research classification. Last year, CSET Senior Fellow, Jaret Riddick, wrote about a new law from Congress, Section 223 of the 2023 National Defense Authorization Act, intended to leverage existing Carnegie classification criteria to increase defense research capacity for historically Black colleges and universities. Now, research is needed to understand how the changes proposed for 2025 classification criteria impact U.S. Department of Defense goals for eligible HBCU partners.

As the U.S. government considers banning genomics companies from China in the Biosecure Act, it opens a broader question of how the U.S. and other market economies should deal with China’s national champions. This blog post provides an overview of BGI and how China’s industrial policy impacts technology development.

As the U.S. government tightens its controls on China’s semiconductor ecosystem, a new dimension is increasingly worrying Congress: the open-source chip architecture known as RISC-V (pronounced “risk-five”). This blog post provides an introduction to the RISC-V architecture and an explanation of what policy-makers can do to address concerns about this open architecture.